Back to today’s briefing

Story perspectives

Psilocybin Shows Promise for Mood Enhancement, Study Finds

3/23/2026

50 3 Full Breakdown

Summary

Story summary

A study in the Journal of Psychopharmacology shows that psilocybin activates the 5-HT2A serotonin receptor, influencing mood.
In mice, a 1.5 mg/kg dose reduces anxiety-like behavior.
A 3 mg/kg dose yields sustained antidepressant effects.
Psilocybin also enhances neuroplasticity by modifying proteins in the prefrontal cortex.
However, the experiment used only male mice and healthy subjects, limiting relevance to human conditions.

1 of 1

Story summary

A study in the Journal of Psychopharmacology shows that psilocybin activates the 5-HT2A serotonin receptor, influencing mood.
In mice, a 1.5 mg/kg dose reduces anxiety-like behavior.
A 3 mg/kg dose yields sustained antidepressant effects.
Psilocybin also enhances neuroplasticity by modifying proteins in the prefrontal cortex.
However, the experiment used only male mice and healthy subjects, limiting relevance to human conditions.